[go: up one dir, main page]

DK1014990T3 - Antitumorkombination af 3 amino-1,2,4 benzotriazin-1,4 dioxid/paclitaxel/platin - Google Patents

Antitumorkombination af 3 amino-1,2,4 benzotriazin-1,4 dioxid/paclitaxel/platin

Info

Publication number
DK1014990T3
DK1014990T3 DK98906594T DK98906594T DK1014990T3 DK 1014990 T3 DK1014990 T3 DK 1014990T3 DK 98906594 T DK98906594 T DK 98906594T DK 98906594 T DK98906594 T DK 98906594T DK 1014990 T3 DK1014990 T3 DK 1014990T3
Authority
DK
Denmark
Prior art keywords
benzotriazine
paclitaxel
dioxide
amino
mammal
Prior art date
Application number
DK98906594T
Other languages
English (en)
Inventor
Daniel L Dexter
Paul E Juniewicz
James B Rake
Hoff Daniel D Von
Original Assignee
Sanofi Aventis Us Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Us Llc filed Critical Sanofi Aventis Us Llc
Application granted granted Critical
Publication of DK1014990T3 publication Critical patent/DK1014990T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK98906594T 1997-03-07 1998-02-17 Antitumorkombination af 3 amino-1,2,4 benzotriazin-1,4 dioxid/paclitaxel/platin DK1014990T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81476997A 1997-03-07 1997-03-07

Publications (1)

Publication Number Publication Date
DK1014990T3 true DK1014990T3 (da) 2006-12-11

Family

ID=25215967

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98906594T DK1014990T3 (da) 1997-03-07 1998-02-17 Antitumorkombination af 3 amino-1,2,4 benzotriazin-1,4 dioxid/paclitaxel/platin

Country Status (15)

Country Link
US (2) US6063780A (da)
EP (1) EP1014990B1 (da)
JP (1) JP2001513110A (da)
AT (1) ATE338553T1 (da)
AU (1) AU6178198A (da)
BR (1) BR9808221A (da)
CA (1) CA2281807C (da)
DE (1) DE69835824T2 (da)
DK (1) DK1014990T3 (da)
ES (1) ES2268764T3 (da)
HR (1) HRP980095A2 (da)
NO (1) NO324974B1 (da)
PT (1) PT1014990E (da)
WO (1) WO1998039009A1 (da)
ZA (1) ZA981609B (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1014990T3 (da) * 1997-03-07 2006-12-11 Sanofi Aventis Us Llc Antitumorkombination af 3 amino-1,2,4 benzotriazin-1,4 dioxid/paclitaxel/platin
CA2346564C (fr) * 1998-10-14 2011-05-03 Debiopharm S.A. Conditionnement d'une preparation d'oxaliplatine
DE19925211B4 (de) * 1999-06-01 2006-01-12 PBS Pharmaceutical Bulk Substances SA Kit zur Herstellung einer Formulierung von Paclitaxel
ES2206288T3 (es) * 1999-08-30 2004-05-16 Debiopharm S.A. Preparacion farmaceutica estable de oxiliplatino para su administracion por via parenteral.
US7070796B1 (en) 1999-08-30 2006-07-04 Debiopharm S.A. Pharmaceutically stable oxaliplatinum preparation for parenteral administration
EP1341555A2 (fr) 2000-12-12 2003-09-10 Debiopharm S.A. Preparation pharmaceutique d'oxaliplatine pour administration par voie parenterale et procede d'obtention de ladite preparation
US6476068B1 (en) 2001-12-06 2002-11-05 Pharmacia Italia, S.P.A. Platinum derivative pharmaceutical formulations
US20040127435A1 (en) * 2002-08-02 2004-07-01 Regents Of The University Of California Uses for inhibitors of inosine monophosphate dehydrogenase
EP1663153A4 (en) * 2003-05-20 2011-01-05 Aronex Pharmaceuticals Inc COMBINATION SCHEMOTHERAPY WITH A LIPOSOMAL PLATINUM COMPLEX
US7989490B2 (en) 2004-06-02 2011-08-02 Cordis Corporation Injectable formulations of taxanes for cad treatment
US20060275331A1 (en) * 2004-08-31 2006-12-07 Borek Zaludek Pharmaceutical composition, method of manufacturing and therapeutic use thereof
JP2006248978A (ja) 2005-03-10 2006-09-21 Mebiopharm Co Ltd 新規なリポソーム製剤
CA2624707A1 (en) * 2005-10-03 2007-04-12 Genetix Pharmaceuticals, Inc. Method for selectively depleting hypoxic cells
US20070212360A1 (en) * 2006-01-17 2007-09-13 Denko Nicholas C Modulation of mitochondrial oxygen consumption for therapeutic purposes
US8026017B2 (en) 2007-03-16 2011-09-27 The United States Of America As Represented By The Secretary Of The Army High voltage methanol fuel cell assembly using proton exchange membranes and base/acid electrolytes
WO2009126705A2 (en) 2008-04-10 2009-10-15 Virginia Commonwealth University Induction of tumor hypoxia for cancer therapy
US9278124B2 (en) 2012-10-16 2016-03-08 Halozyme, Inc. Hypoxia and hyaluronan and markers thereof for diagnosis and monitoring of diseases and conditions and related methods
EP4201403A1 (en) * 2021-12-21 2023-06-28 Som Innovation Biotech, S.L. Compounds tirapazamine and quazinone for use in the treatment of gm2 gangliosidoses

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5399363A (en) * 1991-01-25 1995-03-21 Eastman Kodak Company Surface modified anticancer nanoparticles
US5484612A (en) * 1993-09-22 1996-01-16 The Board Of Trustees Of The Leland Stanford Junior University Method of treating a mammal having a solid tumor susceptible to treatment with cisplatin
DK1014990T3 (da) * 1997-03-07 2006-12-11 Sanofi Aventis Us Llc Antitumorkombination af 3 amino-1,2,4 benzotriazin-1,4 dioxid/paclitaxel/platin

Also Published As

Publication number Publication date
NO324974B1 (no) 2008-01-14
ES2268764T3 (es) 2007-03-16
PT1014990E (pt) 2006-11-30
CA2281807A1 (en) 1998-09-11
DE69835824T2 (de) 2007-03-29
DE69835824D1 (de) 2006-10-19
AU6178198A (en) 1998-09-22
JP2001513110A (ja) 2001-08-28
US6063780A (en) 2000-05-16
HRP980095A2 (en) 1998-12-31
US6319923B1 (en) 2001-11-20
EP1014990B1 (en) 2006-09-06
ATE338553T1 (de) 2006-09-15
CA2281807C (en) 2007-10-16
NO994330D0 (no) 1999-09-06
ZA981609B (en) 1998-12-08
EP1014990A4 (en) 2004-03-24
BR9808221A (pt) 2000-05-16
EP1014990A1 (en) 2000-07-05
WO1998039009A1 (en) 1998-09-11
NO994330L (no) 1999-10-25

Similar Documents

Publication Publication Date Title
DK1014990T3 (da) Antitumorkombination af 3 amino-1,2,4 benzotriazin-1,4 dioxid/paclitaxel/platin
HK1245320A1 (zh) 治療缺陷α半乳糖苷酶A的藥物製劑
TR200002243T2 (tr) Arsenik trioksitin hazırlanması için işlem ve bunların kanser tedavisi için kullanımı.
CY2473B1 (en) New phenanthridines.
DE10199020I2 (de) Galanthamin oder dessen Analoge zur Behandlung derAlzheimerschen Krankheit.
ATE319447T1 (de) Pharmazeutische zubereitungen die clavulansäure oder derivate enthalten zur behandlund von neurologischen störungen
EA200001044A2 (ru) Соединения для лечения женской сексуальной дисфункции
CY1107578T1 (el) Πεπτιδια που χρησιμευουν στη θepαπεια ογκων και αλλων καταστασεων που χρηζουν την αφαιρεση ή την καταστροφη κυτταρων
MXPA03008623A (es) Combinacion farmaceutica para el tratamiento del cancer.
DE69631478D1 (de) Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen
ATE198046T1 (de) Neue hemmer von uridinphosphorylase (urdpase) und dihydrouracildehydrogenase (dhudase)
ATE232394T1 (de) Verwendung von modifiziertem c-reaktiven protein zur herstellung eines medikaments zur behandlung von krebs
EA200200922A1 (ru) Композиция, включающая камптотецин и производное пиримидина, для лечения рака
ID24184A (id) Obat untuk perawatan disfungsi ereksi
ATE204476T1 (de) Verwendung von 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazi e zur herstrllung eines medikaments zur behandlung von bestimmten schmerzen und ödem
DE69635806D1 (de) Diphosphonat derivate von therapeutisch wirksamen stoffen
DE69814691D1 (de) Verwendung von fc101 als hemmstoff der angiogenese zur behandlung von krebs und anderen angiogenen krankheiten
TR200001715T2 (tr) Potasyum kanalı açıcıları.
ATE211650T1 (de) Verwendung von topische präparationen mit glyceryl trinitrat und lanolin zur behandlung von erektilen funktionsstörungen
DE69426986D1 (de) Behandlung von laminitis
EA200300222A1 (ru) Лечение гепатита c с помощью тимозина, интерферона и рибавирина
BR0012380A (pt) 2-amino-benzoxazinonas para o tratamento de vìrus do herpes simples